MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Exploring the Root of Cognitive Decline in People Living with Parkinson’s Disease: An Analysis of MoCA Scores, Neuropsychiatric Symptoms, and Patient-Reported Outcomes

    K. Sánchez-Ramírez, S. Arechavala-Lopez, D. Romero-Terán, A. Hernández-Medrano, M. Medina-Pérez, A. Cervantes-Arriaga, M. Rodríguez-Violante (CULIACAN, Mexico)

    Objective: To evaluate cognitive decline in people living with PD (PwP), to determine to which degree different neuropsychiatric symptoms are risk factors for cognitive decline…
  • 2024 International Congress

    Psychotic features in patients with Parkinson’s disease

    S. Frikha, O. Ben Othmen, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)

    Objective: The objective of the study was to assess the psychotic symptoms associated with Parkinson's disease (PD) and to establish statistical correlations with sociodemographic and…
  • 2024 International Congress

    The Role of Cortisol a Mediator in Influencing Cognitive Function

    DT. Akramova (Tashkent, Uzbekistan)

    Objective: To explore cortisol's impact on cognitive decline and life quality in Parkinson's disease (PD) Background: PD patients exhibit varied symptoms, including cognitive deficits and…
  • 2024 International Congress

    Central Tremor after CAR-T Cell Therapy: A Case with Neurophysiologic Characterization

    O. Halhouli, Z. Ni, H. Cho, M. Hallett (Bethesda, USA)

    Objective: To describe the neurophysiologic characteristics of chimeric antigen receptor (CAR)-T cell therapy-associated tremor. Background: Enhanced physiological tremor is the most common type of drug-induced…
  • 2024 International Congress

    Changes in Parkinson’s Disease and Parkinsonian Syndromes A Comparative Retrospective Study in Kyrgyzstan

    S. Medetbekova, B. Nurbekova (Bishkek, Kyrgyzstan)

    Objective: This study compares Parkinson's disease (PD) and parkinsonian syndromes (PS) in patients at a Kyrgyzstan university hospital. It analyzes data from 2016-2017 [1] and…
  • 2024 International Congress

    Motor and Non-Motor Characteristics of Parkinson’s Disease in a Prevalent Population in Tanzania

    R. Morton, O. Williams, J. Josephat, M. Dekker, W. Howlett, E. Assey, N. Fothergill-Misbah, C. Dotchin, S. Urasa, R. Walker (North Shields, United Kingdom)

    Objective: To determine the features and characteristics of people with Parkinson’s (PwP) identified within a door-to-door prevalence study in Hai District, Tanzania. Background: There is an…
  • 2024 International Congress

    Implementation of the Parkinson’s Disease-Health Index (PD-HI), a Novel, Validated, Disease-Specific Patient-Reported Outcome Measure, in a 24-Month Natural History Study

    J. Purks, J. Seabury, J. Weinstein, A. Varma, S. Rosero, C. Engebrecht, C. Irwin, C. Shupe, A. Arky, J. Heatwole, C. Zizzi, N. Dilek, J. Adams, E. Dorsey, C. Heatwole (Rochester, USA)

    Objective: To evaluate and optimize the relevance, usability and longitudinal responsiveness of the Parkinson’s Disease-Health Index (PD-HI) for use in PD clinical trials. Background: The…
  • 2024 International Congress

    Exercise for Parkinson’s: Building a Person-centered Resource through Partnership

    R. Dolhun, L. Quinn (New York, USA)

    Objective: Create a practical and culturally sensitive guide — considering differences in fitness, age, symptoms, medical conditions, location, etc. — to help people with Parkinson’s…
  • 2024 International Congress

    Is fatigue a rate limiting factor for achieving motor learning and functional gains in people with spinocerebellar ataxia? (PRIME-Ataxia RCT)

    C. Macpherson, F. Awad, V. Rana, S. Kuo, L. Quinn (New York City, USA)

    Objective: Determine the feasibility and preliminary efficacy of an 8-week telehealth intervention of high intensity aerobic exercise prior to balance training (HIBT) compared to low…
  • 2024 International Congress

    Masticatory function evaluation methods in movement disorders

    Y. Navarrete Cortés, P. Castelo, L. Feitosa, G. Azevedo Diaféria, A. Said, C. Ribeiro Neves, O. Barsottini, S. Bommarito (São Paulo, Brazil)

    Objective: To characterize masticatory function in individuals with Parkinson's Disease (PD) and Spinocerebellar Ataxia (SCA3) regarding the orofacial myofunctional condition (OMES-E), the masticatory performance and…
  • « Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley